Early Phase Of Atherosclerosis Imaged

Links shared publicly online about this topic.

  • 723
    total visits

Early Phase Of Atherosclerosis Imaged

medicalnewstoday.com

Atherosclerosis is characterized by hardening and thickening of artery walls, with serious health consequences. Researchers at Eindhoven University of Technology (TU/e) have imaged the stages in t

View full resource at medicalnewstoday.com

Tags: Circulation, Heart Disease, Circulatory Disorders, Atherosclerosis, Healthy Living

  • Share

Most Recently Shared on November 16, 2010 at 5:05 pm By:

Also Shared By:

MNT Vascular MNT Vascular

Positive data from VBL Therapeutics' VB-201 Phase 2 study on psoriasis, atherosclerosis

news-medical.net — “VBL Therapeutics, a clinical stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced that a Phase 2 sub-study of VB-201 in moderate to severe psoriasis patients with cardiovascular risk has successfully achieved its primary endpoint demonstrating a statistically significant reduction in vascular inflammation associated with atherosclerotic lesions as measured by PET-CT imaging.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on March 17, 2012 at 7:37 am By:

Arthritis_News News-Medical.Net Health News

Arthritis News: Positive data from VBL Therapeutics' VB-201 Phase 2 study on psoriasis, atherosclerosis: VBL The... http://t.co/eCFxg2Bp

1 month ago...

PAREXEL implements fMRI technology in early phase CNS drug development

news-medical.net — “PAREXEL International, a leading global biopharmaceutical services provider, today announced that it has enhanced its central nervous system (CNS) capabilities for clinical development through the implementation of functional magnetic resonance imaging (fMRI) technology in its Early Phase units.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on November 22, 2011 at 1:13 pm By:

AlzheimersNews News-Medical.Net Health News

Alzheimers News: PAREXEL implements fMRI technology in early phase CNS drug development: PAREXEL International, ... http://t.co/J4KgBYxU

5 months ago...

Endocrinology Article | Parathyroid Adenomas

mdlinx.com — “Early Planar and Early SPECT Tc-99m Sestamibi Imaging: Can It Replace the Dual-Phase Technique for the Localization of Parathyroid Adenomas by Omitting the Delayed PhaseView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on August 11, 2011 at 10:55 pm By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Early Planar and Early SPECT Tc-99m Sestamibi Imaging: Can It Replace the Dual-Phase Technique for the Loc... http://bit.ly/qwNf8e #endo

9 months ago...

Research Points to Alzheimer's Early Toll - WSJ.com

online.wsj.com — “An explosion of new research bolsters an emerging view that a silent phase of Alzheimer's disease begins ravaging the brain years or even decades before patients have enough symptoms to be diagnosed.View full resource at online.wsj.com

  • View Related
  • Share

Most Recently Shared on August 5, 2011 at 1:38 pm By:

medicallessons elaine schattner Doctor, Internist, Oncologist, Hematologist, and Physician

@garyschwitzer - more on early Alzheimer's tests in WSJ today; brain scan images seeming familiar, all the same? http://on.wsj.com/r1PnCr

9 months ago...

New facilities for developing imaging tests in PESA CNIC-Santander study inaugurated

news-medical.net — “Felipe P-triz, Secretary of State for Research and Emilio Bot-n, president of Banco Santander have inaugurated today in Banco Santander Finantial City (located in Boadilla del Monte) the new facilities for developing the first imaging tests included in PESA (Progression of Early Subclinical Atherosclerosis) CNIC-Santander study.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on February 8, 2011 at 8:17 pm By:

Diagnostic_Test Diagnostic_Test OW Health

New facilities for developing imaging tests in PESA CNIC-Santander study inaugurated: Felipe P-triz, Secretary o... http://bit.ly/faQcQs

1 year ago...

ESMO: Imaging reveals drug's promise in treating urothelial cancer

healthimaging.com — “An ongoing Phase 2 trial investigating Pazopanib, a multitargeted drug with distinct anti-angiogenic activity for metastatic urothelial cancer has generated promising early results, according to a presentation at the 35th Congress of the European Society for Medical Oncology (ESMO) in Milan last week.View full resource at healthimaging.com

  • View Related
  • Share

Most Recently Shared on October 20, 2010 at 1:35 pm By:

HealthImaging Health Imaging & IT Health Magazine

ESMO: Imaging reveals promise of anti-angiogenic drug in treating urothelial cancer http://ow.ly/19xKC2

2 years ago...

JACC: New SPECT agent could detect patients with acute coronary syndrome

healthimaging.com — “The addition of Molecular Insight Pharmaceuticals--™ Zemiva imaging data to initially available clinical information contributes to the early diagnosis and evaluation of myocardial ischemia and acute coronary syndrome, according to a Phase 2 clinical trial published in the July 20 edition of the Journal of the American College of Cardiology (JACC).View full resource at healthimaging.com

  • View Related
  • Share

Most Recently Shared on July 19, 2010 at 1:28 pm By:

HealthImaging Health Imaging & IT Health Magazine

JACC: New SPECT agent could detect patients with acute coronary syndrome http://ow.ly/18cefQ

2 years ago...

Contrast-Enhanced Ultrasound Imaging of the Vasa Vasorum: From Early Atherosclerosis to the Identification of Unstable Plaques -- Staub et al. 3 (7): 761 -- Journal of the American College of Cardiology: Cardiovascular Imaging

imaging.onlinejacc.org — “Contrast-Enhanced Ultrasound Imaging of the Vasa Vasorum: From Early Atherosclerosis to the Identification of Unstable Plaques -- Staub et al. 3 (7): 761 -- Journal of the American College of Cardiology: Cardiovascular ImagingView full resource at imaging.onlinejacc.org

  • View Related
  • Share

Most Recently Shared on July 14, 2010 at 12:17 am By:

jhfrudd James Rudd Physician, Doctor, Internist, and Cardiologist

Contrast-Enhanced Ultrasound Imaging of the Vasa Vasorum: Atherosclerosis to the Identification of Unstable Plaques http://bit.ly/b5RthY

2 years ago...

Imaging Agent Development and Early Phase Clinical Trials « NCI Benchmarks

benchmarks.cancer.gov — “Imaging Agent Development and Early Phase Clinical Trials « NCI BenchmarksView full resource at benchmarks.cancer.gov

  • View Related
  • Share

Most Recently Shared on July 9, 2010 at 3:17 pm By:

NCIMedia NCI Media Relations

New Benchmarks article regarding Imaging Agent Development and Early Phase Clinical Trials: http://bit.ly/aufstY

2 years ago...

Dermoscopy: eMedicine Dermatology

emedicine.medscape.com — “Overview: The widely used acronym ABCDE (asymmetry, irregular borders, multiple colors, diameter 6 mm, enlarging lesion) contains the primary clinical criteria for diagnosing suspected cutaneous malignant melanoma. The early phase of malignant melanoma is difficult to identify because ...View full resource at emedicine.medscape.com

  • View Related
  • Share

Most Recently Shared on March 2, 2010 at 8:37 pm By:

MedscapeDerm Medscape Dermatology Health Site

IDS guidelines on mole mapping updated in Dermoscopy; includes 55+ images: http://bit.ly/dbnVZz

2 years ago...

ASTRO: Post-lumpectomy breast cancer RT can be safely reduced to four weeks

healthimaging.com — “Post-lumpectomy radiation treatment for early-stage breast cancer can be safely reduced to four weeks by delivering a higher daily dose, according to the five-year results of a phase II study presented Wednesday at the 2009 American Society for Radiation Oncology (ASTRO) in Chicago.View full resource at healthimaging.com

  • View Related
  • Share

Most Recently Shared on November 6, 2009 at 1:42 pm By:

HealthImaging Health Imaging & IT Health Magazine

Health Imaging News: ASTRO: Post-lumpectomy breast cancer RT can be saf.. http://tinyurl.com/yl34rry #radiology #imaging

2 years ago...

CAPTIVATE published

theheart.org — “The study is the third in a series of vascular imaging trials to show that ACAT inhibition does not decrease atherosclerosis and the first to suggest it may even promote atherogenesis. Daiichi Sankyo, the drug's sponsor, has already discontinued further study with the once-promising agent. (Meuwese MC et al. JAMA 2009; 301:1131-1139.)View full resource at theheart.org

  • View Related
  • Share

Most Recently Shared on March 17, 2009 at 9:31 pm By:

theheartorg Shelley Wood Cardiology

CAPTIVATE published: Trial stopped early, and pactimibe development discontinued based on IVUS results http://tinyurl.com/dchsw4

3 years ago...

Advertisement